Ventus Therapeutics' lead programs address pathways associated with inflammation. Led by CEO Marcelo Bigal, the biotech discovers its drugs using computational analysis to understand the structure of proteins and find small molecules that can hit these "undruggable" targets.
We are extending our INVEST 2022 Pitch Perfect deadline to Feb 11, 11:59 p.m. ET to allow interested startups to apply to the 4 tracks - PharmaTech, Diagnostics 2.0, Care Coordination and Value-Based Care, and Remote Patient Monitoring and Smart Devices. Slots are going fast so we encourage all startups - particularly those interested to apply in the PharmaTech and Diagnostics tracks to apply immediately. Selected startups will get to pitch LIVE on stage in front of VC judges. Here's the agenda for the INVEST conference.
By Stephanie Baum Wednesday, February 9, 2022 7:07 PM
The agenda includes discussions around 15 themes. They span investment in healthcare, AI, cybersecurity, the use of digital health tools to improve health equity, automation, and revenue models. The conference is scheduled for March 6-9 in Miami Beach.
By Emma Bardin Wednesday, February 9, 2022 6:44 PM
CooperSurgical is set to acquire Cook Medical's Reproductive Health Division to expand its offerings of ob-gyn and fertility medical devices. The deal includes $675M upfront and the remaining $200M paid out in four annual installments.
By Michael Schroeder Wednesday, February 9, 2022 6:03 PM
The Series A financing round was led by F-Prime Capital, with existing investors Lerer Hippeau, NextView Ventures and Amplifyher Ventures also participating. The money will be invested in its platform, hiring additional speech-language pathologists, and partnering with more providers and health plans.
By Stuart Hanson Wednesday, February 9, 2022 6:01 PM
We've been through the beginning phases of interoperability and are solidly transitioning from walking to running. I believe 2022 will be a pivotal year that sees us opening the throttle and rocketing full speed ahead.
By Emma Bardin Wednesday, February 9, 2022 3:34 PM
A report from CoverMyMeds interviewed 1000 patients, doctors, and pharmacists and data indicated a further shift towards digital health, challenges in affording medications, and additional roles taken on by pharmacists.
By Frank Vinluan Wednesday, February 9, 2022 12:51 PM
Ventus Therapeutics' lead programs address pathways associated with inflammation. Led by CEO Marcelo Bigal, the biotech discovers its drugs using computational analysis to understand the structure of proteins and find small molecules that can hit these "undruggable" targets.
By Glen Lawrence Wednesday, February 9, 2022 10:00 AM
Today, we see too many doctors working with their blinders on, either too busy to learn what is happening to independent healthcare or unaware that AI can reinvigorate their practice.
By Emma Bardin Wednesday, February 9, 2022 9:00 AM
Scopio Labs secured $50M in series C funding, which the company will use to scale manufacturing of its FDA-cleared imaging and AI analysis platform to support the shift to fully telehematology.
No comments